ANA-12
ANA-12
ANA-12 is a small molecule that acts as a selective antagonist of the tropomyosin receptor kinase B (TrkB), which is the high-affinity receptor for brain-derived neurotrophic factor (BDNF). ANA-12 is of interest in the field of neuroscience and pharmacology due to its potential therapeutic applications in neurological disorders and psychiatric disorders.
Mechanism of Action
ANA-12 functions by selectively inhibiting the activity of TrkB receptors. TrkB is a member of the neurotrophin receptor family and is primarily activated by BDNF. The binding of BDNF to TrkB initiates a cascade of intracellular signaling pathways that are crucial for neuronal survival, synaptic plasticity, and cognitive function. By antagonizing TrkB, ANA-12 can modulate these pathways, which may be beneficial in conditions where BDNF signaling is dysregulated.
Potential Therapeutic Applications
Research into ANA-12 has suggested several potential therapeutic applications:
- Depression: Dysregulation of BDNF and TrkB signaling has been implicated in the pathophysiology of depression. ANA-12, by modulating this pathway, may offer a novel approach to treating depression.
- Anxiety disorders: Similar to depression, anxiety disorders may involve altered BDNF signaling. ANA-12 could potentially be used to address these alterations.
- Neurodegenerative diseases: Conditions such as Alzheimer's disease and Parkinson's disease involve neurodegeneration where BDNF-TrkB signaling plays a protective role. Modulating this pathway with ANA-12 might offer neuroprotective benefits.
Research and Development
ANA-12 is primarily used in preclinical research settings. Studies have demonstrated its ability to cross the blood-brain barrier, making it a valuable tool for in vivo studies of TrkB function. Ongoing research is focused on understanding the full range of its effects and potential side effects in various models of disease.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
